Fundz
Real-time · AI · Cross-signal

Ikerian AG just moved. Here's exactly what to do next.

Who to reach, what to say, and why now — on Ikerian AG, plus every contract, funding round, and exec hire that follows. Verified, ICP-ranked contacts on demand (email + mobile).

Used by professionals at BlackRock, Oracle, Kleiner Perkins, HubSpot, and other leading firms — built on 10 years of proprietary signal data.

Choose your planRequest a demo
▶
Watch the 2-minute tour · with sound

Ikerian Secures Series B Funding of USD 8M and Forms Commercial Partnership with Sanoptis

Oct 16, 2024•over 1 year ago

Contract Type

partnership

BiotechnologyHealth CareArtificial IntelligenceMachine Learning

Description

Ikerian AG and its subsidiary, RetinAI U.S. Inc., have successfully closed the first round of their Series B financing, raising USD 8M. Sanoptis, a strategic investor, has led this funding round. The investment aims to accelerate the development of Discovery CONNECT™, a software solution for automating imaging data uploads within clinical workflows and networks

Company Information

Company

Ikerian AG

About

Ikerian AG, formerly known as RetinAI Medical AG, specialises in software solutions that leverage advanced machine learning and computer vision to accelerate clinical, research, and pharmaceutical workflows globally. As part of a strategic shift, the company is actively exploring opportunities in emerging therapeutic domains, such as neurodegenerative disorders, vascular conditions, and rare diseases.

Predictive Intelligence
Strategic

ML-powered predictions for Ikerian AG's next move

Learn about Strategic plan

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.